AU4058100A - Generic cdna or protein array for customized assays - Google Patents

Generic cdna or protein array for customized assays

Info

Publication number
AU4058100A
AU4058100A AU40581/00A AU4058100A AU4058100A AU 4058100 A AU4058100 A AU 4058100A AU 40581/00 A AU40581/00 A AU 40581/00A AU 4058100 A AU4058100 A AU 4058100A AU 4058100 A AU4058100 A AU 4058100A
Authority
AU
Australia
Prior art keywords
cdna
generic
protein array
customized
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40581/00A
Inventor
Thomas M Baer
Steven T. Kunitake
Ann Bennett Lossing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arcturus Engineering Inc
Original Assignee
Arcturus Engineering Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcturus Engineering Inc filed Critical Arcturus Engineering Inc
Publication of AU4058100A publication Critical patent/AU4058100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
AU40581/00A 1999-04-09 2000-03-31 Generic cdna or protein array for customized assays Abandoned AU4058100A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12857899P 1999-04-09 1999-04-09
US60128578 1999-04-09
US53886200A 2000-03-29 2000-03-29
US09538862 2000-03-29
PCT/US2000/008611 WO2000061806A2 (en) 1999-04-09 2000-03-31 GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS

Publications (1)

Publication Number Publication Date
AU4058100A true AU4058100A (en) 2000-11-14

Family

ID=26826721

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40581/00A Abandoned AU4058100A (en) 1999-04-09 2000-03-31 Generic cdna or protein array for customized assays

Country Status (3)

Country Link
EP (1) EP1183387A2 (en)
AU (1) AU4058100A (en)
WO (1) WO2000061806A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425138D0 (en) 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid
GB0016836D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (1)
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
WO2003006657A2 (en) * 2001-07-13 2003-01-23 Custos Biotechnologie Gmbh Gene-regulatory elements for gene therapy, for the prevention and diagnosis of metastases and for the gene therapy of tumours
EP1468116A2 (en) * 2002-01-16 2004-10-20 Dynal Biotech ASA Method for isolating nucleic acids and protein from a single sample
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
KR100690948B1 (en) 2004-06-17 2007-03-09 한국과학기술원 Method for Cell Surface Display of Target Proteins Using FadL of E. coli
KR100784261B1 (en) 2006-01-02 2007-12-11 한국과학기술원 Method for Cell Surface Displaying of Target Proteins Using Bacillus anthracis Exosporium
DK3255146T3 (en) 2009-03-16 2019-08-19 Pangu Biopharma Ltd Compositions and Methods comprising Histidyl-tRNA Synthetase Splicing Variants with Non-Canonical Biological Activities
AU2010236913B2 (en) 2009-03-31 2016-03-24 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
JP6294074B2 (en) 2010-04-27 2018-03-14 エータイアー ファーマ, インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of isoleucyl-tRNA synthetase
CA2797271C (en) 2010-04-28 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
CA2797393C (en) 2010-04-29 2020-03-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
EP2563936B1 (en) 2010-04-29 2018-03-14 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy
CN103097523B (en) 2010-04-29 2016-09-28 Atyr医药公司 The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Asparaginyl-tRNA synthetase finds
AU2011248227B2 (en) 2010-05-03 2016-12-01 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
CN103096925A (en) 2010-05-03 2013-05-08 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-tRNA synthetases
ES2668207T3 (en) 2010-05-03 2018-05-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic and antibody compositions related to fragments of methionyl-tRNA synthetases proteins
CN102985103A (en) 2010-05-04 2013-03-20 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
US8945541B2 (en) 2010-05-14 2015-02-03 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
CA2799480C (en) 2010-05-17 2020-12-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
EP2575856B1 (en) 2010-05-27 2017-08-16 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
EP2575857B1 (en) 2010-06-01 2018-01-24 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
WO2012021247A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
CA2808539C (en) 2010-08-25 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
JP6039656B2 (en) 2011-06-01 2016-12-07 メディカル プログノシス インスティテュート エー/エス Method and apparatus for predicting prognosis of cancer recurrence
US8835387B2 (en) 2012-02-16 2014-09-16 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
CA2892822C (en) 2012-11-27 2023-08-08 Pontificia Universidad Catolica De Chile Compositions and methods for diagnosing thyroid tumors
US10392667B2 (en) 2013-06-07 2019-08-27 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
WO2016008048A1 (en) 2014-07-15 2016-01-21 Ontario Institute For Cancer Research Methods and devices for predicting anthracycline treatment efficacy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8920097D0 (en) * 1989-09-06 1989-10-18 Ici Plc Amplification processes
JPH06509946A (en) * 1992-06-17 1994-11-10 シティ・オブ・ホープ How to detect and identify nucleic acids
ATE244406T1 (en) * 1993-05-10 2003-07-15 Nissui Pharm Co Ltd METHOD FOR DETERMINING MORE THAN ONE IMMUNOLOGICAL LIGAND AND DETERMINATION REAGENT AND SET THEREOF
EP0920440B1 (en) * 1996-02-09 2012-08-22 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US5804384A (en) * 1996-12-06 1998-09-08 Vysis, Inc. Devices and methods for detecting multiple analytes in samples
AU8267998A (en) * 1997-06-24 1999-01-04 Trustees Of Boston University High density streptavidin supports
DE19741716A1 (en) * 1997-09-22 1999-03-25 Hoechst Ag Recognition system
US6232066B1 (en) * 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
GB9902970D0 (en) * 1999-02-11 1999-03-31 Zeneca Ltd Novel matrix
WO2000058516A2 (en) * 1999-03-26 2000-10-05 Whitehead Institute For Biomedical Research Universal arrays

Also Published As

Publication number Publication date
WO2000061806A3 (en) 2001-12-20
EP1183387A2 (en) 2002-03-06
WO2000061806A2 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
AU4058100A (en) Generic cdna or protein array for customized assays
AU5173400A (en) Protein kinases
AU4488200A (en) Modified protein matrices
AU6906800A (en) Membrane associated proteins
AU1701001A (en) Antibodies against signal regulator proteins
AU1290001A (en) Antibodies
AU2434199A (en) Protein
AU3440900A (en) Assay system
AU4935000A (en) Antibodies
AU2925600A (en) Genetic screening
AU6123899A (en) Supports for immobilizing dna or the like
AU6045900A (en) Interaction-activated proteins
AU3902099A (en) Tethered function assay for protein function
AU3162500A (en) Homogeneous fluorescence assay
AU2190801A (en) Binding protein
AU4188500A (en) Protein c derivatives
AU2452301A (en) Protein methylarginine-specific antibodies
AU4352000A (en) Clasp-2 transmembrane proteins
AU1531801A (en) Novel assay
AU1751801A (en) Protein c derivatives
AU7537400A (en) Assay
AU1881200A (en) Novel proteins
AU4245500A (en) Protein transport assays
AU2538899A (en) Protein kinase c
AU6983000A (en) Chimeric proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase